These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37597212)
21. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer. Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441 [TBL] [Abstract][Full Text] [Related]
22. Identification of the Expression of TIE1 and Its Mediated Immunosuppression in Gastric Cancer. Gong Z; Zheng Q; Li B; Wang H; Chen H; Lin S J Cancer; 2024; 15(10):2994-3009. PubMed ID: 38706903 [No Abstract] [Full Text] [Related]
23. Semaphorin4F is a potential biomarker for clinical progression and prognosis in gastric cancer. Wang H; Ji X; Chen L; Ju L; Ma Q; Wu Y; Cai W Int J Clin Exp Pathol; 2023; 16(9):210-224. PubMed ID: 37818383 [TBL] [Abstract][Full Text] [Related]
24. HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients. Wang S; Zhang S; Li X; Li X; Zhao S; Guo J; Wang S; Wang R; Zhang M; Qiu W Front Immunol; 2024; 15():1415148. PubMed ID: 39108265 [TBL] [Abstract][Full Text] [Related]
25. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature. Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384 [TBL] [Abstract][Full Text] [Related]
26. Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma. He Z; Yang H; Chen Q; Chen YP; Qin H; He W; Chen Z J Gastrointest Oncol; 2024 Jun; 15(3):890-907. PubMed ID: 38989426 [TBL] [Abstract][Full Text] [Related]
27. Pan-cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer. Ju Y; Wang Z; Wang Q; Jin S; Sun P; Wei Y; Zhu G; Wang K J Cell Mol Med; 2024 Aug; 28(15):e18579. PubMed ID: 39086142 [TBL] [Abstract][Full Text] [Related]
28. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
29. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma. Huang S; Hou Y; Hu M; Hu J; Liu X BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627 [TBL] [Abstract][Full Text] [Related]
30. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer. Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682 [No Abstract] [Full Text] [Related]
31. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer. Feng L; Li G; Li D; Duan G; Liu J J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594 [TBL] [Abstract][Full Text] [Related]
32. Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer. Wang X; Wang Y; Sun F; Xu Y; Zhang Z; Yang C; Zhang L; Lou G Front Oncol; 2022; 12():945518. PubMed ID: 35903691 [TBL] [Abstract][Full Text] [Related]
33. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing. Chen M; Zhu X; Zhang L; Zhao D BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519 [TBL] [Abstract][Full Text] [Related]
34. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer. Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405 [TBL] [Abstract][Full Text] [Related]
35. NRSN2 is a Prognostic Biomarker in Gastric Cancer and Facilitates the Growth and Migration of Gastric Cancer Cells. Ren S; Chen M; Chen Y; Ding K Protein Pept Lett; 2023; 30(5):427-438. PubMed ID: 36918782 [TBL] [Abstract][Full Text] [Related]
36. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma. Yan J; Xie X; Li Q; Liang P; Zhang J; Xu G Heliyon; 2023 Feb; 9(2):e13613. PubMed ID: 36852051 [TBL] [Abstract][Full Text] [Related]
37. REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer. Liu GH; Tan XY; Xu ZY; Li JX; Zhong GH; Zhai JW; Li MY Sci Rep; 2024 Jun; 14(1):13834. PubMed ID: 38879709 [TBL] [Abstract][Full Text] [Related]
38. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer. Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164 [TBL] [Abstract][Full Text] [Related]
39. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma. Wang J; Wu N; Feng X; Liang Y; Huang M; Li W; Hou L; Yin C Front Immunol; 2022; 13():1052692. PubMed ID: 36685506 [TBL] [Abstract][Full Text] [Related]
40. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer. Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]